Total liabilities · 2017–2025
Kiniksa Pharmaceuticals International total liabilities
$196M+37.9% · FY2025
Kiniksa Pharmaceuticals International (KNSA) reported $196M in total liabilities for fiscal 2025, +37.9% year on year.
| Fiscal year | Total liabilities | Change | Filing |
|---|---|---|---|
| FY20252025-12-31 | $196M | +37.9% | Open → |
| FY20242024-12-31 | $142M | +62.5% | Open → |
| FY20232023-12-31 | $87.5M | +37.7% | Open → |
| FY20222022-12-31 | $63.5M | +33.0% | Open → |
| FY20212021-12-31 | $47.8M | +27.3% | Open → |
| FY20202020-12-31 | $37.5M | +28.9% | Open → |
| FY20192019-12-31 | $29.1M | −31.8% | Open → |
| FY20182018-12-31 | $42.7M | +145.0% | Open → |
| FY20172017-12-31 | $17.4M | — | Open → |
Total liabilities — Total liabilities is everything the company owes at the balance-sheet date — debt, payables, deferred revenue and provisions together. Where a filer does not tag it, we calculate it as total assets minus total equity and label the figure as calculated.
Every row links to its own SEC filing · Fiscal year 2025 · Data as of September 25, 2026 · 2017–2025 compound annual growth +35.3%
Total liabilities at companies of similar size
Cite this page
Ready-made references for the figures on this page, as published on September 25, 2026.
Wikipedia
{{cite web |title=Kiniksa Pharmaceuticals International total liabilities |url=https://companiesranked.com/en/company/kiniksa-pharmaceuticals-international/total-liabilities |website=CompaniesRanked |date=2026-09-25 |language=en}}APA 7
CompaniesRanked. (September 25, 2026). Kiniksa Pharmaceuticals International total liabilities. CompaniesRanked. https://companiesranked.com/en/company/kiniksa-pharmaceuticals-international/total-liabilitiesBibTeX
@misc{companiesranked-en-company-kiniksa-pharmaceuticals-international-total-liabilities-2026,
author = {{CompaniesRanked}},
title = {{Kiniksa Pharmaceuticals International total liabilities}},
year = {2026},
howpublished = {\url{https://companiesranked.com/en/company/kiniksa-pharmaceuticals-international/total-liabilities}},
note = {Compiled from SEC EDGAR XBRL filings; data as of 2026-09-25},
urldate = {2026-09-25}
}The filing itself
The numbers above are read from this document: 10-Q · 0001104659-26-087545 · July 28, 2026
{{cite web |title=Kiniksa Pharmaceuticals International total liabilities — 10-Q (0001104659-26-087545) |url=https://www.sec.gov/Archives/edgar/data/1730430/000110465926087545/knsa-20260630x10q.htm |website=SEC EDGAR |publisher=U.S. Securities and Exchange Commission |date=2026-07-28}}The figures are rebuilt with every data refresh, so the reference carries the publication date. Add your own access date if your style requires one.